The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT 1A receptor

By Jordan S.   Koprivica V.   Chen R.   Tottori K.   Kikuchi T.   Altar C.A.  

European Journal of Pharmacology, Vol. 441, Iss. 3, 2002-04 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite

F15063, a potential antipsychotic with dopamine D₂/D₃ antagonist, 5-HT_1A agonist and D₄ partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D₁ agonist and D₂ antagonist

By Natesan Sridhar   Reckless Greg   Barlow Karen   Odontiadis John   Nobrega José   Baker Glen   George Susan   Mamo David   Kapur Shitij  

Psychopharmacology, Vol. 199, Iss. 2, 2008-08 ,pp. : 275-289

Springer Publishing Company

Access to resources Recommend Favorite

The preferential dopamine D 3 receptor ligand, (+)-UH 232, is a partial agonist

By Griffon N.   Pilon C.   Schwartz J.-C.   Sokoloff P.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

By Wood M.D.   Boyfield I.   Nash D.J.   Jewitt F.R.   Avenell K.Y.   Riley G.J.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite